Chiesi to market Aggrastat for Iroko
This article was originally published in Scrip
Executive Summary
Chiesi has become the exclusive distributor of Iroko Cardio's antithrombotic Aggrastat (tirofiban HCl) in 19 European countries, after being granted promotion, marketing and commercialisation rights on undisclosed terms.